{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:43:30Z","timestamp":1792583010189,"version":"4.5.0"},"reference-count":32,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5UM1 AI144462 03"],"award-info":[{"award-number":["5UM1 AI144462 03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021281","name":"Gates Family Foundation","doi-asserted-by":"publisher","award":["INV\u2010070116"],"award-info":[{"award-number":["INV\u2010070116"]}],"id":[{"id":"10.13039\/100021281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biotech &amp; Bioengineering"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The successful translation of rationally designed HIV\u20101 immunogens into effective vaccines requires manufacturing platforms that maintain structural conformity while meeting clinical\u2010grade quality standards. We developed and scaled up a robust, cGMP\u2010compliant process for N332\u2010GT5 gp140, a germline\u2010targeting envelope trimer designed to initiate broadly neutralizing antibody responses, which is now undergoing first\u2010in\u2010human evaluation in HVTN144. Starting with a stable CHO cell line developed using Leap\u2010In\u00ae transposon technology, we established a production clone exhibiting high\u2010titer expression (&gt;\u2009200\u2009mg\/L) and genetic stability through 60 population doublings. The manufacturing process scaled up efficiently from Ambr\u00ae 250 miniature bioreactors to 200\u2010L single\u2010use systems, delivering consistent product quality across multiple cGMP batches. A streamlined three\u2010step purification strategy\u2014affinity capture, multimodal polishing, and viral clearance \u2014yielded &gt;\u200999% trimeric purity while preserving quaternary structure and native\u2010like antigenicity. Orthogonal LC\u2010MS analyses confirmed site\u2010specific glycan occupancy matching design specifications, while robust viral clearance exceeded 18\u2010log and 11\u2010log reductions for model retroviruses. Clinical material manufactured through this platform has been successfully administered in clinical trial HVTN144. This work establishes a scalable, reproducible manufacturing paradigm for structurally complex HIV\u20101 envelope immunogens, advancing the field toward rational vaccine design based on germline\u2010targeting principles.<\/jats:p>","DOI":"10.1002\/bit.70409","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:11:39Z","timestamp":1792581099000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Translating Innovation to Clinic: End\u2010to\u2010End Bioprocess Development and cGMP Manufacturing of N332\u2010GT5 HIV Vaccine Candidate for First\u2010In\u2010Human Trials (HVTN144)"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7973-0332","authenticated-orcid":false,"given":"Sammaiah","family":"Pallerla","sequence":"first","affiliation":[{"name":"IAVI New York City New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaunak D.","family":"Uplekar","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7380-899X","authenticated-orcid":false,"given":"Ferenc","family":"Boldog","sequence":"additional","affiliation":[{"name":"ATUM Bio Newark California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4589-5322","authenticated-orcid":false,"given":"James C.","family":"Paulson","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-5160","authenticated-orcid":false,"given":"Sabyasachi","family":"Baboo","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-1672","authenticated-orcid":false,"suffix":"III","given":"John R.","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen\u2010Hsin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-8138","authenticated-orcid":false,"given":"Gabriel","family":"Ozorowski","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-968X","authenticated-orcid":false,"given":"Joel D.","family":"Allen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Southampton Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-2694","authenticated-orcid":false,"given":"Max","family":"Crispin","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Southampton Southampton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-3083","authenticated-orcid":false,"given":"Chris","family":"Cottrell","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Integrative Structural and Computational Biology The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Sitaraman","sequence":"additional","affiliation":[{"name":"ATUM Bio Newark California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Broderick","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Costakes","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolette","family":"McCombs","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Ryan","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Wolfe","sequence":"additional","affiliation":[{"name":"KBI Biopharma Durham North Carolina USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Craig","sequence":"additional","affiliation":[{"name":"IAVI New York City New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Syvertsen","sequence":"additional","affiliation":[{"name":"IAVI New York City New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert E.","family":"Price","sequence":"additional","affiliation":[{"name":"IAVI New York City New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon M.","family":"Steichen","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology The Scripps Research Institute La Jolla California USA"},{"name":"IAVI Neutralizing Antibody Center The Scripps Research Institute La Jolla California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Schief","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology The Scripps Research Institute La Jolla California USA"},{"name":"IAVI Neutralizing Antibody Center The Scripps Research Institute La Jolla California USA"},{"name":"Center for HIV\/AIDS Vaccine Immunology and Immunogen Discovery The Scripps Research Institute La Jolla California USA"},{"name":"Moderna, Inc. Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c03059"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/bs.mie.2022.09.004","article-title":"DeGlyPHER: Highly Sensitive Site\u2010Specific Analysis of N\u2010Linked Glycans on Proteins","volume":"682","author":"Baboo S.","year":"2023","journal-title":"Methods in Enzymology"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-025-01218-6","article-title":"Accelerated cGMP Production of Near\u2010Native HIV\u20101 Env Trimers Following Electroporation Transfection and Immunogenicity Analysis","volume":"10","author":"Bale S.","year":"2025","journal-title":"NPJ Vaccines"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01894-16"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design","volume":"34","author":"Burton D. R.","year":"2016","journal-title":"Annual Review of Immunology"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14954","article-title":"Global Site\u2010Specific N\u2010Glycosylation Analysis of HIV Envelope Glycoprotein","volume":"8","author":"Cao L.","year":"2017","journal-title":"Nature Communications"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.26498"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/febs.13530"},{"issue":"9","key":"e_1_2_12_10_1","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02428-16","article-title":"Glycosylation Benchmark Profile for HIV\u20101 Envelope Glycoprotein Production Based on Eleven Env Trimers","volume":"91","author":"Go E. P.","year":"2017","journal-title":"Journal of Virology"},{"key":"e_1_2_12_11_1","unstructured":"HIV Vaccine Trials Network. HVTN 144: A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of N332\u2010GT5 gp140 Adjuvanted With SMNP. ClinicalTrials.gov Identifier: NCT05217641.2025."},{"key":"e_1_2_12_12_1","first-page":"253","article-title":"Antibodies to the Envelope Glycoproteins of HIV\u20101: Structure, Function, and Mechanisms of Action","volume":"51","author":"Klasse P. J.","year":"2012","journal-title":"Progress in Lipid Research"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV\u20101 Vaccines Based on Antibody Identification, B\u2010Cell Ontogeny, and Epitope Structure","volume":"48","author":"Kwong P. D.","year":"2018","journal-title":"Immunity"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.103913"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nmeth.1195","article-title":"A Quantitative Analysis Software Tool for Mass Spectrometry\u2010Based Proteomics","volume":"5","author":"Park S. K.","year":"2008","journal-title":"Nature Methods"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ady6831"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/pr025556v","article-title":"Evaluation of Multidimensional Chromatography Coupled With Tandem Mass Spectrometry (LC\/LC\u2212MS\/MS) for Large\u2010Scale Protein Analysis: The Yeast Proteome","volume":"2","author":"Peng J.","year":"2003","journal-title":"Journal of Proteome Research"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/btpr.1874","article-title":"High\u2010Throughput Miniaturized Bioreactors for Cell Culture Process Development: Reproducibility, Scalability, and Control","volume":"30","author":"Rameez S.","year":"2014","journal-title":"Biotechnology Progress"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adw0721"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4223"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4155\/pbp.14.62","article-title":"Viral Clearance for Biopharmaceutical Downstream Processes","volume":"3","author":"Shukla A. A.","year":"2015","journal-title":"Pharmaceutical Bioprocessing"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1152","article-title":"A Particulate Saponin\/TLR Agonist Vaccine Adjuvant Alters Lymph Flow and Modulates Adaptive Immunity","volume":"6","author":"Silva M.","year":"2021","journal-title":"Science Immunology"},{"key":"e_1_2_12_23_1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2105\/AJPH.2020.306138","article-title":"The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution","volume":"111","author":"Socal M. P.","year":"2021","journal-title":"American Journal of Public Health"},{"issue":"3","key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV Vaccine Design to Target Germline Precursors of Glycan\u2010Dependent Broadly Neutralizing Antibodies","volume":"45","author":"Steichen J. M.","year":"2016","journal-title":"Immunity"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj8321","article-title":"Vaccine Priming of Rare HIV Broadly Neutralizing Antibody Precursors in Nonhuman Primates","volume":"384","author":"Steichen J. M.","year":"2024","journal-title":"Science"},{"key":"e_1_2_12_26_1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax4380","article-title":"A Generalized HIV Vaccine Design Strategy for Priming of Broadly Neutralizing Antibody Responses","volume":"366","author":"Steichen J. M.","year":"2019","journal-title":"Science"},{"key":"e_1_2_12_27_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated Molecular Microscopy: The New Leginon System","volume":"151","author":"Suloway C.","year":"2005","journal-title":"Journal of Structural Biology"},{"key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/pr015504q","article-title":"DTASelect and Contrast: Tools for Assembling and Comparing Protein Identifications From Shotgun Proteomics","volume":"1","author":"Tabb D. L.","year":"2002","journal-title":"Journal of Proteome Research"},{"key":"e_1_2_12_29_1","unstructured":"UNAIDS. Global HIV & AIDS Statistics 2025Fact Sheet.https:\/\/www.unaids.org."},{"key":"e_1_2_12_30_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16567-0","article-title":"Vulnerabilities in Coronavirus Glycan Shields Despite Extensive Glycosylation","volume":"11","author":"Watanabe Y.","year":"2020","journal-title":"Nature Communications"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.vaccine.2021.05.073","article-title":"Development of a Platform\u2010Based Approach for the Clinical Production of HIV gp120 Envelope Glycoprotein Vaccine Candidates","volume":"39","author":"Wolfe L. S.","year":"2021","journal-title":"Vaccine"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01470"},{"key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jprot.2015.07.001","article-title":"ProLuCID: An Improved SEQUEST\u2010Like Algorithm With Enhanced Sensitivity and Specificity","volume":"129","author":"Xu T.","year":"2015","journal-title":"Journal of Proteomics"}],"container-title":["Biotechnology and Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bit.70409","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bit.70409","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bit.70409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:11:43Z","timestamp":1792581103000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bit.70409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":32,"alternative-id":["10.1002\/bit.70409"],"URL":"https:\/\/doi.org\/10.1002\/bit.70409","archive":["Portico"],"relation":{},"ISSN":["0006-3592","1097-0290"],"issn-type":[{"value":"0006-3592","type":"print"},{"value":"1097-0290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"2026-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"bit.70409"}}